Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't ...

Johnson & Johnson (NYSE:JNJ) is one of the best pharma stocks to invest in now. Johnson & Johnson (NYSE:JNJ) announced on March 28 that randomized controlled trial (RCT) data presented at the ...

The biggest names in cardiology tech gathered in New Orleans for the American College of Cardiology (ACC) Scientific Sessions ...

Microaxial flow pump circulatory support with the Impella device during percutaneous coronary intervention (PCI) didn't help outcomes for complex patients not in cardiogenic shock, two randomized ...

The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally delaying percutaneous coronary intervention (PCI), also known as coronary ...

This screenshot from an Abiomed video demonstrates placement of the Impella 2.5 and Impella CP. Delivered in a minimally invasive way, Impella pumps actively unload the heart, aiding native heart ...

Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't have cardiogenic shock does not significantly reduce heart damage. That is ...

In the STEMI Door-to-Unload trial, use of Impella missed the mark in patients with anterior MI without cardiogenic shock.

Two brief reports in JACC on the DOBERMANN-T and DOBERMANN-D trials found that among patients with acute myocardial infarction (AMI) at increased risk of cardiogenic shock (CS), early interleukin‑6 ...